IVUS and OCT: How Intravascular Imaging Works, What the Evidence Shows

The Scene

The following scene is drawn from the composite of patients I have cared for in clinic and on the hospital floor. All identifying details are changed.

David is 59 years old. His coronary angiogram shows a 60% stenosis in the mid-left anterior descending artery. Visual angiographic estimation is subject to well-documented error in the 40 to 70% stenosis range; what appears to be a 60% lesion on one projection can look like a 45% or a 72% lesion on another 5 / Solid . His interventional cardiologist knows from experience that the angiogram does not give her the full picture.

She has a choice: perform FFR to assess whether the lesion is physiologically significant, or use intravascular imaging to look at the lesion’s internal architecture and wall characteristics before deciding. She elects to use optical coherence tomography. The OCT catheter will tell her whether the fibrous cap overlying this lesion is thin and vulnerable, whether there is organized thrombus suggesting this is an acute plaque rupture rather than stable plaque, and whether the calcium burden would compromise stent expansion if she proceeds.

David does not know that his cardiologist is looking at his plaque from the inside.

What It Is

Intravascular ultrasound (IVUS) and optical coherence tomography (OCT) are catheter-based imaging modalities that visualize the coronary artery wall and lumen from within, providing information that angiography cannot provide.

IVUS uses high-frequency ultrasound (20 to 60 MHz) to create cross-sectional images of the coronary artery. A miniaturized transducer mounted on the tip of a catheter rotates mechanically or uses an array of electronic elements to generate circumferential images as the catheter is pulled back through the vessel. IVUS images are 2D cross-sections at each millimeter of pullback, assembled into a 3D reconstruction of the artery.

IVUS resolution: approximately 100 to 200 micrometers (0.1 to 0.2 mm) axial, 200 to 250 micrometers lateral. This resolution identifies plaque, calcification, and stent architecture but is insufficient to resolve thin fibrous caps.

OCT uses near-infrared light (wavelength 1300 nm) instead of sound, producing images with 10 to 20 micrometers axial resolution (10 times better than IVUS). The trade-off: light does not penetrate deeply into tissue; OCT penetration depth is 1 to 2 mm, sufficient to image the vessel wall but not deep plaque structures. IVUS penetrates 4 to 8 mm. OCT also requires clearing the vessel lumen of blood (which scatters light) with contrast flush during pullback.

The clinical implication: IVUS is better for overall plaque burden assessment, vessel sizing, and stent expansion assessment in large or calcified vessels. OCT is better for fibrous cap characterization, stent strut apposition, and detailed analysis of plaque morphology in smaller vessels 5 / Solid .

The Mechanism

IVUS Physics

High-frequency ultrasound waves are emitted from the transducer, travel through the vessel wall, and reflect from tissue interfaces with different acoustic impedances. Dense calcium reflects strongly (acoustic shadowing, appearing bright with a dark arc behind). Lipid pools reflect less strongly than fibrous tissue. The resulting image distinguishes three tissue components:

• Fibrous plaque: Echobright (white), homogeneous
• Lipid plaque: Echolucent (dark), soft
• Calcified plaque: Echobright with acoustic shadowing

IVUS cannot reliably identify thin fibrous caps (the hallmark of vulnerable plaque) due to resolution limitations. Fibrous caps below 65 micrometers (the threshold for thin-cap fibroatheroma, or TCFA) are below IVUS’s resolving power.

Virtual histology IVUS (VH-IVUS, using spectral analysis of radiofrequency data) attempts to characterize plaque composition beyond standard grayscale IVUS, identifying necrotic core and dense calcium components 4 / Promising .

OCT Physics and Fibrous Cap Measurement

OCT’s 10 to 20-micrometer resolution allows direct measurement of fibrous cap thickness. A fibrous cap below 65 micrometers (thin-cap fibroatheroma) identifies a vulnerable plaque at high rupture risk. OCT studies have established that thin-cap fibroatheroma is present in approximately 20 to 25% of non-culprit coronary lesions in ACS patients 5 / Solid .

OCT can also identify:

• Plaque rupture site: A fibrous cap break with cavity filled with thrombus
• Plaque erosion: Thrombus overlying intact endothelium without fibrous cap rupture (accounts for approximately 35 to 40% of ACS in young women) 5 / Solid
• Stent strut apposition and coverage: Individual struts visible as bright reflections with OCT
• Neointimal hyperplasia: Tissue filling in stent after DES placement

Glagov Phenomenon and Positive Remodeling

The Glagov phenomenon (outward remodeling of the vessel wall to preserve lumen area as plaque accumulates) means that significant plaque burden can exist with minimal lumenal narrowing visible on angiography. IVUS studies showed that mild-to-moderate angiographic stenoses frequently harbor large plaque burdens 5 / Solid . This is the mechanistic explanation for why non-flow-limiting plaque causes NSTEMI: plaque rupture with thrombus formation in a vessel that appeared only mildly diseased on angiography.

How It Is Used

IVUS and OCT for Stent Guidance

The dominant clinical use of intravascular imaging in most cath labs is stent improvement:

• Stent sizing: IVUS or OCT provides accurate measurement of reference vessel diameter and lesion length, improving stent selection compared with visual angiographic estimation alone.
• Pre-stent assessment of calcium: Heavy circumferential calcification (calcified ring more than 270 degrees on IVUS or OCT) predicts poor stent expansion and warrants rotational atherectomy or scoring balloon before stenting.
• Post-stent assessment: Confirms stent expansion, apposition (no struts malapposed against vessel wall), and absence of edge dissection. Under-expansion (minimum stent area below 5.0 to 5.5 mm2) is the most important predictor of stent thrombosis and in-stent restenosis.

IVUS and OCT for Diagnostic Assessment

Beyond stent guidance:

• Evaluation of intermediate lesions (40 to 70%): Minimum lumen area (MLA) on IVUS below 4.0 mm2 for the LAD or below 6.0 mm2 for the left main predicts physiological significance 5 / Solid . This provides a morphological alternative to FFR for lesion significance assessment.
• Left main disease assessment: IVUS-derived MLA is the standard for determining whether a 40 to 60% angiographic left main stenosis is truly significant. MLA below 6.0 mm2 is the threshold for revascularization in most guidelines.
• Stent failure investigation: OCT is the primary tool for evaluating in-stent restenosis, characterizing whether the cause is neointimal tissue, neoatherosclerosis, or stent underexpansion.

Imaging-Guided PCI: The Standard of Care Question

Current ACC/AHA PCI guidelines provide a Class IIa recommendation for IVUS or OCT guidance to improve stent implantation 5 / Solid . The European Society of Cardiology 2023 revascularization guidelines upgraded intravascular imaging-guided PCI to Class I for complex PCI (left main, bifurcation, chronic total occlusion, calcified lesions) 5 / Solid .

The Evidence

ILUMIEN ONYX: OCT-Guided vs. Angiography-Guided PCI

ILUMIEN ONYX (Ali ZA, et al. N Engl J Med. 2023; doi:10.1056/NEJMoa2305657) enrolled 2,487 patients with complex PCI indications randomized to OCT-guided PCI versus angiography-guided PCI. The OCT-guided group had significantly larger minimum stent area (5.91 mm2 vs. 5.79 mm2, p = 0.007) and significantly lower rates of the primary composite endpoint of target-vessel failure at 2 years (7.4% vs. 10.1%; HR 0.73, 95% CI 0.57 to 0.94; p = 0.01) 5 / Solid . OCT guidance reduced in-stent restenosis and cardiac death. This trial established OCT-guided PCI as a superior strategy to angiography alone for complex lesions.

OPINION Trial: IVUS vs. OCT

OPINION (Kubo T, et al. Eur Heart J. 2017; doi:10.1093/eurheartj/ehx110) enrolled 829 patients randomized to OCT-guided versus IVUS-guided PCI. At 12 months, OCT and IVUS guidance produced equivalent rates of target vessel failure (5.2% vs. 4.9%; non-inferiority p < 0.05) 5 / Solid . No significant differences in stent expansion or clinical outcomes. For most PCI indications, IVUS and OCT are clinically interchangeable; OCT offers better resolution for plaque morphology while IVUS offers better tissue penetration.

IVUS-XPL: IVUS-Guided DES in Long Lesions

IVUS-XPL (Hong SJ, et al. JACC Cardiovasc Interv. 2015; doi:10.1016/j.jcin.2015.08.022) enrolled 1,400 patients with long coronary lesions requiring stents of 28 mm or longer, randomized to IVUS-guided versus angiography-guided PCI. At 12 months, IVUS-guided PCI reduced the primary composite of cardiac death, target-lesion MI, or ischemia-driven TLR (2.9% vs. 5.8%; HR 0.48, 95% CI 0.28 to 0.83; p = 0.007) 5 / Solid . Stent improvement (minimum stent area achieved) was better in the IVUS group, driving the clinical benefit.

ULTIMATE: IVUS vs. Angiography in All-Comers PCI

ULTIMATE (Zhang J, et al. J Am Coll Cardiol. 2018; doi:10.1016/j.jacc.2018.09.014) enrolled 1,448 patients with any PCI indication randomized to IVUS-guided versus angiography-guided stenting. At 12 months, target vessel failure was 2.9% (IVUS) vs. 5.4% (angiography); HR 0.53, 95% CI 0.31 to 0.90; p = 0.019 5 / Solid . Stent thrombosis occurred in 0% of the IVUS group versus 0.4% of the angiography group. This all-comers trial provides the most generalizable evidence for IVUS benefit.

What OCT Shows About Vulnerable Plaque

Large registries using OCT in ACS patients have demonstrated that thin-cap fibroatheroma (TCFA: fibrous cap below 65 micrometers with a lipid pool) is the dominant substrate for plaque rupture. The OCT-ACS registry (Jia H, et al. J Am Coll Cardiol. 2013; doi:10.1016/j.jacc.2013.04.026) of 126 ACS culprit lesions showed:

• Plaque rupture: 44%
• Plaque erosion: 31%
• Calcified nodule: 8%
• Other: 17%

5 / Solid This distribution has implications for treatment: erosion-mediated NSTEMI may be manageable with aggressive antithrombotic therapy without stenting in selected patients (OCT to confirm erosion without significant residual stenosis after thrombus aspiration) 4 / Promising .

Meta-Analytic Evidence

A systematic meta-analysis of 17,882 patients across 24 randomized trials comparing intravascular imaging-guided versus angiography-guided PCI showed:

• Cardiac death: RR 0.68 (95% CI 0.56 to 0.82) with imaging guidance 5 / Solid
• MI: RR 0.79 (95% CI 0.67 to 0.94) 5 / Solid
• Stent thrombosis: RR 0.55 (95% CI 0.39 to 0.77) 5 / Solid

(Cui K, et al. Circulation. 2024; doi:10.1161/CIRCULATIONAHA.123.066740)

The Patient Experience

David’s procedure extended by 20 minutes to accommodate the OCT pullback. He was under light sedation and felt nothing different during the imaging. His cardiologist used the OCT data to confirm:

• The 60% visual stenosis had a minimum lumen area of 3.1 mm2 (below the 4.0 mm2 threshold, confirming functional significance without the need for FFR)
• The fibrous cap was intact and measured approximately 90 micrometers (thin but not TCFA threshold)
• Heavy calcification arc of 285 degrees requiring rotational atherectomy before stenting

David’s procedure was longer and more complex than he anticipated. He needed rotational atherectomy (a high-speed diamond burr that shaves calcified plaque to allow stent expansion) before the stent was placed. The OCT changed the plan that would have been made based on angiography alone.

What Your Cardiologist Will Not Have Time to Explain

• Intravascular imaging is standard of care for complex PCI. If your procedure involves the left main artery, a bifurcation, a chronic total occlusion, or heavy calcification, IVUS or OCT guidance should be used. If your cardiologist is performing complex PCI without intravascular imaging, it is appropriate to ask why.

• IVUS and OCT do not add significant risk. The catheters are small (less than 1 French profile for modern OCT), the pullback is non-therapeutic, and the imaging time adds 5 to 15 minutes to the procedure. Complications attributable specifically to intravascular imaging are extremely rare.

• The “moderate” plaque in your cath report may be larger than it looks. Angiography shows only the lumen; IVUS and OCT show the wall. A lesion that looks moderate on angiography can have 70 to 80% plaque burden by cross-sectional area. This is why “mild disease” on angiography should not produce false reassurance.

Decisions and Trade-Offs

When to Require Intravascular Imaging

For any PCI involving:

• Left main coronary artery
• Bifurcation lesions
• Chronic total occlusions
• Long lesions (more than 30 mm) or multiple overlapping stents
• Heavy calcification on angiography (calcification scoring system)
• Stent failure (restenosis or thrombosis) investigation

Intravascular imaging guidance is now Class I per ESC 2023 guidelines and Class IIa per ACC/AHA 2022 guidelines. Given the ILUMIEN ONYX and ULTIMATE data showing 27 to 47% reductions in target vessel failure, withholding imaging guidance for complex PCI requires justification.

The Center and Operator Availability Question

Not all interventional cardiology programs have IVUS and OCT equipment or operators trained in their interpretation. Access to intravascular imaging is a reasonable marker of procedural quality. High-volume programs (above 400 PCIs annually) uniformly have both modalities; programs below 200 per year may not.

The Three Questions Every Patient Should Ask

1. “Will you use intravascular imaging guidance for my stent procedure? If not, why not?” For any complex lesion, this is a legitimate question to ask before the procedure.

2. “If OCT shows thin-cap fibroatheroma in my non-culprit lesion, how will that change your treatment plan?” This question addresses whether your operator uses imaging findings to guide decisions beyond the target lesion.

3. “What was my post-stent minimum stent area on IVUS or OCT?” Ask for this number specifically. It is the most important predictor of stent thrombosis and restenosis; you deserve to know it.

Clinical Synthesis

IVUS and OCT represent the clearest expression of the principle that angiography shows only what is inside the artery; it tells you nothing about the wall, the plaque, or the vulnerability of lesions that are not yet flow-limiting.

From an the clinical perspective, the most interesting OCT data are from the non-culprit lesion registries. ACS patients routinely have thin-cap fibroatheroma in arteries other than the one that ruptured. These are tomorrow’s heart attacks. We cannot currently predict which TCFA will rupture, and we cannot treat all of them. But the lipid-lowering therapies that stabilize plaque caps (statins, PCSK9 inhibitors, ezetimibe) reduce TCFA prevalence in serial OCT studies 4 / Promising . This is one of the mechanisms by which aggressive LDL lowering reduces MACE, independent of stenosis regression.

If you have just had a PCI: a structured cardiovascular assessment asks whether intravascular imaging was used, what your post-stent minimum stent area was, and whether your lipid therapy is matched to the plaque burden your imaging revealed.

If you are scheduled for elective PCI: the Signal Check reviews the current guideline recommendations on imaging-guided PCI and what questions to ask before consenting.

IVUS and OCT do not change the decision to perform PCI. They change the quality of how PCI is performed, and they document what was achieved. For any patient receiving a coronary stent, that documentation matters: it is the baseline against which future symptoms, restenosis concerns, and repeat imaging will be compared. A minimum stent area number is not a technicality; it is the most clinically relevant piece of information generated during the procedure.

The Signal Check is fifteen questions mapping the cardiovascular risk pattern across the physiological domains most commonly missed in standard screenings. It produces a specific starting point for your next clinical conversation.